{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:54:57Z","timestamp":1781639697798,"version":"3.54.5"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 AI164565"],"award-info":[{"award-number":["UM1 AI164565"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019546","name":"Einstein Rockefeller-CUNY Center","doi-asserted-by":"publisher","award":["1P30 AI124414-01A1"],"award-info":[{"award-number":["1P30 AI124414-01A1"]}],"id":[{"id":"10.13039\/100019546","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Advances in basic and translational human immunodeficiency virus (HIV-1) research have refined our understanding of viral persistence while informing new strategies aimed at prevention and durable virologic control. Here, we present an overview of selected advances in HIV vaccine development, cure-directed strategies, and new insights into the mechanisms of HIV persistence, highlighting key basic and translational studies published over the past year and featured in What's Hot in HIV Basic Science 2025. Notable progress includes promising results in germline-targeting and sequential immunization for the induction of broadly neutralizing antibody precursors, a better understanding of the mechanisms of reservoir persistence, and encouraging signals that immune-based strategies can lead to postintervention control. Collectively, these insights emphasize the value of experimental medicine trials and underscore a shift toward more precise, mechanism-informed strategies for HIV prevention and cure, pointing to a future in which durable virologic control may be achievable through rationally designed combination approaches.<\/jats:p>","DOI":"10.1093\/infdis\/jiag135","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T12:23:08Z","timestamp":1772454188000},"page":"e1313-e1319","source":"Crossref","is-referenced-by-count":0,"title":["What's Hot in HIV in 2025\u2014A Basic and Translational Science Review From IDWeek 2025"],"prefix":"10.1093","volume":"233","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1906-0102","authenticated-orcid":false,"given":"Ana Rafaela","family":"Teixeira","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Immunology, The Rockefeller University , NewYork, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1727-8693","authenticated-orcid":false,"given":"Marina","family":"Caskey","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Immunology, The Rockefeller University , NewYork, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"2026061615213247500_jiag135-B1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41579-023-00914-1","article-title":"Prevention, treatment and cure of HIV infection","volume":"21","author":"Landovitz","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"2026061615213247500_jiag135-B2","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S0140-6736(24)00302-7","article-title":"Under threat: the International AIDS Society-Lancet Commission on Health and Human Rights","volume":"403","author":"Beyrer","year":"2024","journal-title":"Lancet"},{"key":"2026061615213247500_jiag135-B3","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1056\/NEJMoa2031738","article-title":"Two randomized trials of neutralizing antibodies to prevent HIV-1 acquisition","volume":"384","author":"Corey","year":"2021","journal-title":"N Engl J Med"},{"key":"2026061615213247500_jiag135-B4","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1126\/science.adp3459","article-title":"Progress on priming HIV-1 immunity","volume":"384","author":"Sanders","year":"2024","journal-title":"Science"},{"key":"2026061615213247500_jiag135-B5","doi-asserted-by":"crossref","first-page":"eadd6502","DOI":"10.1126\/science.add6502","article-title":"Vaccination induces HIV broadly neutralizing antibody precursors in humans","volume":"378","author":"Leggat","year":"2022","journal-title":"Science"},{"key":"2026061615213247500_jiag135-B6","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1016\/j.cell.2024.04.033","article-title":"Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans","volume":"187","author":"Williams","year":"2024","journal-title":"Cell"},{"key":"2026061615213247500_jiag135-B7","doi-asserted-by":"crossref","first-page":"eadv5572","DOI":"10.1126\/science.adv5572","article-title":"Precise targeting of HIV broadly neutralizing antibody precursors in humans","volume":"389","author":"Caniels","year":"2025","journal-title":"Science"},{"key":"2026061615213247500_jiag135-B8","doi-asserted-by":"crossref","first-page":"eadr8382","DOI":"10.1126\/science.adr8382","article-title":"Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans","volume":"389","author":"Willis","year":"2025","journal-title":"Science"},{"key":"2026061615213247500_jiag135-B9","doi-asserted-by":"crossref","first-page":"eadm7097","DOI":"10.1126\/sciimmunol.adm7097","article-title":"Immunization with germ line-targeting SOSIP trimers elicits broadly neutralizing antibody precursors in infant macaques","volume":"9","author":"Nelson","year":"2024","journal-title":"Sci Immunol"},{"key":"2026061615213247500_jiag135-B10","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1016\/S1473-3099(23)00481-4","article-title":"Vaccinating people living with HIV: a fast track to preventive and therapeutic HIV vaccines","volume":"24","author":"Trkola","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2026061615213247500_jiag135-B11","doi-asserted-by":"publisher","author":"Ferreira","year":"2026","DOI":"10.1038\/s41586-026-10298-w"},{"key":"2026061615213247500_jiag135-B12","doi-asserted-by":"crossref","first-page":"e20251584","DOI":"10.1084\/jem.20251584","article-title":"Transcription of HIV-1 is heterogenous among authentic latent CD4+ T cell clones","volume":"223","author":"Bittar","year":"2026","journal-title":"J Exp Med"},{"key":"2026061615213247500_jiag135-B13","doi-asserted-by":"crossref","first-page":"e171554","DOI":"10.1172\/JCI171554","article-title":"The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy","volume":"133","author":"McMyn","year":"2023","journal-title":"J Clin Invest"},{"key":"2026061615213247500_jiag135-B14","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1172\/JCI124291","article-title":"Intact HIV-1 proviruses accumulate at distinct chromosomal positions during prolonged antiretroviral therapy","volume":"129","author":"Einkauf","year":"2019","journal-title":"J Clin Invest"},{"key":"2026061615213247500_jiag135-B15","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cell.2021.12.011","article-title":"Parallel analysis of transcription, integration, and sequence of single HIV-1 proviruses","volume":"185","author":"Einkauf","year":"2022","journal-title":"Cell"},{"key":"2026061615213247500_jiag135-B16","doi-asserted-by":"crossref","first-page":"e20211427","DOI":"10.1084\/jem.20211427","article-title":"Integration features of intact latent HIV-1 in CD4+ T cell clones contribute to viral persistence","volume":"218","author":"Huang","year":"2021","journal-title":"J Exp Med"},{"key":"2026061615213247500_jiag135-B17","doi-asserted-by":"crossref","first-page":"e20240391","DOI":"10.1084\/jem.20240391","article-title":"Transcription of HIV-1 at sites of intact latent provirus integration","volume":"221","author":"Teixeira","year":"2024","journal-title":"J Exp Med"},{"key":"2026061615213247500_jiag135-B18","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1016\/j.immuni.2025.07.022","article-title":"Transcription factor BACH2 shapes tissue-resident memory T cell programs to promote HIV-1 persistence","volume":"58","author":"Wei","year":"2025","journal-title":"Immunity"},{"key":"2026061615213247500_jiag135-B19","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/QAD.0000000000001443","article-title":"Demographics and natural history of HIV-1-infected spontaneous controllers of viremia","volume":"31","author":"Yang","year":"2017","journal-title":"AIDS"},{"key":"2026061615213247500_jiag135-B20","doi-asserted-by":"crossref","first-page":"e139287","DOI":"10.1172\/jci.insight.139287","article-title":"Reduced HIV-1 latent reservoir outgrowth and distinct immune correlates among women in Rakai, Uganda","volume":"5","author":"Prodger","year":"2020","journal-title":"JCI Insight"},{"key":"2026061615213247500_jiag135-B21","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/infdis\/jiy617","article-title":"Sex-based differences in human immunodeficiency virus type 1 reservoir activity and residual immune activation","volume":"219","author":"Scully","year":"2019","journal-title":"J Infect Dis"},{"key":"2026061615213247500_jiag135-B22","doi-asserted-by":"crossref","first-page":"eadu7154","DOI":"10.1126\/scitranslmed.adu7154","article-title":"Sex differences in HIV-1 reservoir cell selection are linked to altered innate immune profiles","volume":"17","author":"Tan","year":"2025","journal-title":"Sci Transl Med"},{"key":"2026061615213247500_jiag135-B23","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/jmp.12613","article-title":"The role of latency reversal in HIV cure strategies","volume":"51","author":"Tanaka","year":"2022","journal-title":"J Med Primatol"},{"key":"2026061615213247500_jiag135-B24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coviro.2019.03.004","article-title":"Between a shock and a hard place: challenges and developments in HIV latency reversal","volume":"38","author":"Zerbato","year":"2019","journal-title":"Curr Opin Virol"},{"key":"2026061615213247500_jiag135-B25","doi-asserted-by":"crossref","first-page":"e0041723","DOI":"10.1128\/aac.00417-23","article-title":"A truncated HIV tat demonstrates potent and specific latency reversal activity","volume":"67","author":"Van Gulck","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"2026061615213247500_jiag135-B26","doi-asserted-by":"crossref","first-page":"e0020124","DOI":"10.1128\/aac.00201-24","article-title":"Nanoparticle delivery of Tat synergizes with classical latency reversal agents to express HIV antigen targets","volume":"68","author":"Raines","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"key":"2026061615213247500_jiag135-B27","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/mt.2016.7","article-title":"Specific reactivation of latent HIV-1 by dCas9-SunTag-VP64-mediated guide RNA targeting the HIV-1 promoter","volume":"24","author":"Ji","year":"2016","journal-title":"Mol Ther"},{"key":"2026061615213247500_jiag135-B28","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/mt.2015.213","article-title":"CRISPR-mediated Activation of latent HIV-1 expression","volume":"24","author":"Limsirichai","year":"2016","journal-title":"Mol Ther"},{"key":"2026061615213247500_jiag135-B29","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/mt.2015.202","article-title":"Potent and targeted activation of latent HIV-1 using the CRISPR\/dCas9 activator complex","volume":"24","author":"Saayman","year":"2016","journal-title":"Mol Ther"},{"key":"2026061615213247500_jiag135-B30","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1038\/s41467-025-60001-2","article-title":"Efficient mRNA delivery to resting T cells to reverse HIV latency","volume":"16","author":"Cevaal","year":"2025","journal-title":"Nat Commun"},{"key":"2026061615213247500_jiag135-B31","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41586-018-0531-2","article-title":"Combination therapy with anti-HIV-1 antibodies maintains viral suppression","volume":"561","author":"Mendoza","year":"2018","journal-title":"Nature"},{"key":"2026061615213247500_jiag135-B32","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/COH.0000000000000890","article-title":"Post-intervention control in HIV immunotherapy trials","volume":"20","author":"Sandel","year":"2025","journal-title":"Curr Opin HIV AIDS"},{"key":"2026061615213247500_jiag135-B33","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1038\/s41467-025-57284-w","article-title":"Safety, immunogenicity and effect on viral rebound of HTI vaccines combined with a TLR7 agonist in early-treated HIV-1 infection: a randomized, placebo-controlled phase 2a trial","volume":"16","author":"Bailon","year":"2025","journal-title":"Nat Commun"},{"key":"2026061615213247500_jiag135-B34","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/s41586-022-04597-1","article-title":"Prolonged viral suppression with anti-HIV-1 antibody therapy","volume":"606","author":"Gaebler","year":"2022","journal-title":"Nature"},{"key":"2026061615213247500_jiag135-B35","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1038\/s41591-023-02547-6","article-title":"Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial","volume":"29","author":"Gunst","year":"2023","journal-title":"Nat Med"},{"key":"2026061615213247500_jiag135-B36","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1038\/s41591-022-02023-7","article-title":"Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b\/2a, randomized trial","volume":"28","author":"Gunst","year":"2022","journal-title":"Nat Med"},{"key":"2026061615213247500_jiag135-B37","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1038\/s41591-024-03247-5","article-title":"Safety and antiviral effect of a triple combination of HIV-1 broadly neutralizing antibodies: a phase 1\/2a trial","volume":"30","author":"Julg","year":"2024","journal-title":"Nat Med"},{"key":"2026061615213247500_jiag135-B38","author":"Fidler","year":"2025"},{"issue":"8100","key":"2026061615213247500_jiag135-B39","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41586-025-09929-5","article-title":"Correlates of HIV-1 control after combination immunotherapy","volume":"650","author":"Peluso","year":"2025","journal-title":"Nature"},{"key":"2026061615213247500_jiag135-B40","author":"Dong","year":"2025"},{"key":"2026061615213247500_jiag135-B41","author":"Dorrell","year":"2025"},{"key":"2026061615213247500_jiag135-B42","author":"Fumagalli"},{"key":"2026061615213247500_jiag135-B43","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41591-019-0747-1","article-title":"Combination anti-HIV-1 antibody therapy is associated with increased virus-specific T cell immunity","volume":"26","author":"Niessl","year":"2020","journal-title":"Nat Med"},{"key":"2026061615213247500_jiag135-B44","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.1038\/s41467-022-34171-2","article-title":"Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8(+) T cell immunity","volume":"13","author":"Rosas-Umbert","year":"2022","journal-title":"Nat Commun"},{"key":"2026061615213247500_jiag135-B45","author":"Frater","year":"2025"},{"key":"2026061615213247500_jiag135-B46","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41586-025-09932-w","article-title":"CD8(+) T cell stemness precedes post-intervention control of HIV viraemia","volume":"650","author":"Kiani","year":"2026","journal-title":"Nature"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiag135\/67210801\/jiag135.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/233\/6\/e1313\/67210801\/jiag135.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/233\/6\/e1313\/67210801\/jiag135.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T19:21:43Z","timestamp":1781637703000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/233\/6\/e1313\/8504273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,3,3]]},"published-print":{"date-parts":[[2026,6,16]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiag135","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6,15]]},"published":{"date-parts":[[2026,3,3]]}}}